INLX vs REFR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits severe financial weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' health category. Despite a strong gross margin of 66.05%, the business is struggling with stagnant revenue growth (1.00% YoY) and negative profitability (ROE -17.01%). The technical trend is completely bearish (0/100), and the stock has lost over 53% of its value in the last year. With a Forward P/E of 116.67 and no meaningful growth catalysts, the current valuation is difficult to justify.
REFR presents a critical risk profile, characterized by a Piotroski F-Score of 5/9 which masks severe operational decay. The company is suffering from catastrophic profitability metrics, including a negative gross margin of -128.55% and a YoY revenue collapse of -59.50%. With only $0.7 million in cash and a Price-to-Book ratio of 33.22, the stock is trading at a massive premium despite facing significant liquidity risks and a history of operating losses. The combination of a 0/100 technical trend and critical funding needs makes this a highly speculative and fundamentally broken investment.
Compare Another Pair
Related Comparisons
INLX vs REFR: Head-to-Head Comparison
This page compares Intellinetics, Inc. (INLX) and Research Frontiers Incorporated (REFR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.